Multiple sclerosis and Hashimoto thyroiditis: Two cases

Neurologist

Volumn 11, Issue 5, 2005, Pages 301-304

  Petek Balci, Belgin ^a   Yayla, Vildan ^a   Özer, Feriha ^a,b  

^a Haseki Educational Research Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

Autoimmune disease; Hashimoto thyroiditis; Multiple sclerosis; Thyroid disorders

Indexed keywords

ALEMTUZUMAB; BETA INTERFERON; BETAHISTINE; CD4 ANTIGEN; CD52 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; LIOTHYRONINE; METHYLPREDNISOLONE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; DISEASE ASSOCIATION; FATIGUE; FEMALE; HASHIMOTO DISEASE; HUMAN; IMMUNITY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYALGIA; PATHOGENESIS; PRIORITY JOURNAL; THYROID FUNCTION TEST;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEOPLASM; ANTIRHEUMATIC AGENTS; FEMALE; HASHIMOTO DISEASE; HUMANS; INTERFERON TYPE I, RECOMBINANT; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MUSCLE FATIGUE; MUSCLE WEAKNESS; THYROID HORMONES;

EID: 24944543831     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000162956.40653.38     Document Type: Article

References (33)

1. Weiner HL. The 21 point unifying hypothesis on etiology and treatment of multiple sclerosis. Can J Neural Sci. 1998;25:93-101.
2. Wertman E, Zilber N, Abramsky O. An association between multiple sclerosis and type I diabetes mellitus. J. Neurol. 1992;239:43-45.
3. Tourbah A, Clapin A, Gout O, et al. Systemic autoimmune features and multiple sclerosis. Arch Neurol. 1998;55:517-521.
4. Midgard R, Gronning M, Ruse T, et al. Multiple sclerosis and chronic inflammatory disease. Acta Neurol Scand. 1996;93:322-328.
5. Lo R, Feasby TE. Multiple sclerosis and autoimmune disease. Neurology. 1983;33:97-98.
6. Wang C, Crapo LM. The epidemiology of thyroid disease and implications for screening. Endocrinol Metab Clin North Am. 1997;26:189-218.
7. Braverman LE, Utiger RD. Introduction to hypothyroidism. In: Werner, Ingbar, eds. The Thyroid-A Fundamental and Clinical Text. Philadelphia: JB Lippincott; 1991:919-920.
8. Karni A, Abramsky O. Association of MS with thyroid disorders. Neurology. 1999;53:883-885.
9. Eto S. Hashimoto disease. Nippon Rinsho. 1999;57:1749-1754.
10. Vanderpump MPJ, Tunbridge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham survey. Clin Endocrinol. 1995;43:55-68.
11. Larsen PR. Thyroidal triodothyroxine in Graves' disease: correlation with presurgical treatment, thyroid status and iodine content. J Clin Endocrinol Metab. 1975;41:1098-1104.
12. Friedel J, Jeandel C, Abensour M, et al. Multiple sclerosis and autoimmune skin bullae: a case of pemphigus vulgaris. Dermatologica. 1987;175:159-160.
13. Attout H, Toussirot E, Auge B, et al. Rheumatoid arthritis and multiple sclerosis in the same patient. Two case reports. Rev Rheum Engl Ed. 1999;66:169-172.
14. Roquer J, Escudero D, Herraiz J, et al. Multiple sclerosis and Hashimoto's thyroiditis. J Neurol. 1987;234:23-24.
15. Cindoruk M, Yetkin I, Karakan T, et al. The prevalence of autoimmune hepatitis in Hashimoto's thyroiditis in a Turkish population. Acta Gastroenterol Belg. 2002;65:143-145.
16. Ciampolillo A, Guastamacchia E, Amati L, et al. Modifications of the immune responsiveness in patients with autoimmune thyroiditis: evidence for a systemic immune alteration. Curr Pharm Des. 2003;9:1946-1950.
17. Penhale WJ, Farmer A, Irvine WJ. Thyroiditis in T cell-depleted rats. Influence of strain, radiation dose, adjuvants and antilymphocytes serum. Clin Exp Immunol. 1975;21:362-375.
18. Watanabe M, Amino N, Hochito K, et al. Opposite chances in serum soluble CD8 in patients at the active stages of Graves' and Hashimoto's diseases. Thyroid. 1997;7:743-747.
19. Fowell D, Mason D. Evidence that the T cell repertoire of normal rats contains cells with the potential to cause diabetes: characterization of the CD4 T cell subset that inhibits this autoimmune potential. J Exp Med. 1993;177:627-636.
20. Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid. 2002;12:977-988.
21. Palillo A, Coles AJ, Molyneux PD, et al. Quantitative MRI in patients with secondary progressive MS treated with monoclonal antibody Campath IH. Neurology. 1999;53:751-757.
22. Multiple sclerosis encyclopedia. Available at www.mult-sclerosis.org/ Campath1H.html.
23. Benjamin RJ, Waidmann H. Induction of tolerance by monoclonal antibody therapy. Nature. 1986;320:449-451.
24. Coles AJ, Wing M, Smith S, et al. Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis. Lancet. 1999;354:1691-1695.
25. Moreau T, Thorpe J, Miller DH, et al. Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis. Lancet. 1994;344:298-301.
26. Hafler DA, Fallis RJ, Dawson DM, et al. Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T 12. Neurology. 1986;36:777-784.
27. Van Oosten BW, Lai M, Hodgkinson S, et al. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology. 1997;49:351-357.
28. Larsen PR, Davies TF, Hay ID. The thyroid gland. In: Wilson JD, Foster DW, Kronenberg HM, et al, eds. Williams Textbook of Endocrinology. 9th ed. Philadelphia: WB Saunders; 1998:475-479.
29. Byme OC, Zuberi SM, Madigan CA, et al. Hashimoto's thyroiditis a rare but treatable cause of encephalopathy in children. Eur J Paediatr Neurol. 2000;4:279-282.
30. Schauble B, Castillo PR, Boeve BF, et al. EEG findings in steroid-responsive encephalopathy associated with autoimmune thyroiditis. Clin Neurophysiol. 2003;114:32-37.
31. Ghika-Schmid F, Ghika J, Regli F, et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition? Move Disord. 1996;11:555-562.
32. Schwid SR, Goodman AD, Mattson D. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b. Arch Neurol. 1997;54:1169-1190.
33. Adorini L. Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis. J Chemother. 2001;13:219-234.